FDAnews Drug Daily Bulletin

ENHANCE BIOTECH ANNOUNCES ASSET SALE AGREEMENT WITH MOUNT COOK BIOSCIENCES

May 23, 2006
A A

Enhance Biotech, Inc., a company developing a portfolio of products focused on lifestyle drugs, announced today that it has sold its opioid Delta receptor compound portfolio to Mount Cook Biosciences Inc., a company formed and funded by Paramount Biosciences, LLC of New York.
PrimeZone